Cargando…
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194836/ https://www.ncbi.nlm.nih.gov/pubmed/34050372 http://dx.doi.org/10.1093/jtm/taab083 |
| _version_ | 1783706445858996224 |
|---|---|
| author | Abu-Raddad, Laith J Chemaitelly, Hiam Yassine, Hadi M Benslimane, Fatiha M Al Khatib, Hebah A Tang, Patrick Malek, Joel A Coyle, Peter Ayoub, Houssein H Al Kanaani, Zaina Al Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul Rahim, Hanan F Nasrallah, Gheyath K Al Kuwari, Mohamed Ghaith Al Romaihi, Hamad Eid Al-Thani, Mohamed H Al Khal, Abdullatif Butt, Adeel A Bertollini, Roberto |
| author_facet | Abu-Raddad, Laith J Chemaitelly, Hiam Yassine, Hadi M Benslimane, Fatiha M Al Khatib, Hebah A Tang, Patrick Malek, Joel A Coyle, Peter Ayoub, Houssein H Al Kanaani, Zaina Al Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul Rahim, Hanan F Nasrallah, Gheyath K Al Kuwari, Mohamed Ghaith Al Romaihi, Hamad Eid Al-Thani, Mohamed H Al Khal, Abdullatif Butt, Adeel A Bertollini, Roberto |
| author_sort | Abu-Raddad, Laith J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8194836 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81948362021-06-15 Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses Abu-Raddad, Laith J Chemaitelly, Hiam Yassine, Hadi M Benslimane, Fatiha M Al Khatib, Hebah A Tang, Patrick Malek, Joel A Coyle, Peter Ayoub, Houssein H Al Kanaani, Zaina Al Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul Rahim, Hanan F Nasrallah, Gheyath K Al Kuwari, Mohamed Ghaith Al Romaihi, Hamad Eid Al-Thani, Mohamed H Al Khal, Abdullatif Butt, Adeel A Bertollini, Roberto J Travel Med Rapid Communication Oxford University Press 2021-05-28 /pmc/articles/PMC8194836/ /pubmed/34050372 http://dx.doi.org/10.1093/jtm/taab083 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of International Society of Travel Medicine. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Rapid Communication Abu-Raddad, Laith J Chemaitelly, Hiam Yassine, Hadi M Benslimane, Fatiha M Al Khatib, Hebah A Tang, Patrick Malek, Joel A Coyle, Peter Ayoub, Houssein H Al Kanaani, Zaina Al Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul Rahim, Hanan F Nasrallah, Gheyath K Al Kuwari, Mohamed Ghaith Al Romaihi, Hamad Eid Al-Thani, Mohamed H Al Khal, Abdullatif Butt, Adeel A Bertollini, Roberto Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses |
| title | Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses |
| title_full | Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses |
| title_fullStr | Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses |
| title_full_unstemmed | Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses |
| title_short | Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses |
| title_sort | pfizer-biontech mrna bnt162b2 covid-19 vaccine protection against variants of concern after one versus two doses |
| topic | Rapid Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194836/ https://www.ncbi.nlm.nih.gov/pubmed/34050372 http://dx.doi.org/10.1093/jtm/taab083 |
| work_keys_str_mv | AT aburaddadlaithj pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT chemaitellyhiam pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT yassinehadim pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT benslimanefatiham pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT alkhatibhebaha pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT tangpatrick pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT malekjoela pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT coylepeter pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT ayoubhousseinh pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT alkanaanizaina pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT alkuwarieinas pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT jeremijenkoandrew pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT kaleeckalanvarhassan pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT latifalinizar pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT shaikriyazuddinmohammad pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT abdulrahimhananf pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT nasrallahgheyathk pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT alkuwarimohamedghaith pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT alromaihihamadeid pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT althanimohamedh pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT alkhalabdullatif pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT buttadeela pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses AT bertolliniroberto pfizerbiontechmrnabnt162b2covid19vaccineprotectionagainstvariantsofconcernafteroneversustwodoses |